PAGE 1 OF 1. REQUISITION NO.

2. CONTRACT NO. 3. AWARD/EFFECTIVE DATE 4. ORDER NO. 5. SOLICITATION NUMBER 6. SOLICITATION ISSUE DATE

a. NAME b. TELEPHONE NO. (No Collect Calls) 8. OFFER DUE DATE/LOCAL

TIME

9. ISSUED BY CODE 10. THIS ACQUISITION IS UNRESTRICTED OR SET ASIDE: % FOR:

SMALL BUSINESS

HUBZONE SMALL

BUSINESS

SERVICE-DISABLED

VETERAN-OWNED

SMALL BUSINESS

WOMEN-OWNED SMALL BUSINESS

(WOSB) ELIGIBLE UNDER THE WOMEN-OWNED

SMALL BUSINESS PROGRAM

EDWOSB

8(A)

NAICS:

SIZE STANDARD:

11. DELIVERY FOR FOB DESTINA-

TION UNLESS BLOCK IS

MARKED

SEE SCHEDULE

12. DISCOUNT TERMS

13a. THIS CONTRACT IS A

RATED ORDER UNDER

DPAS (15 CFR 700)

13b. RATING

14. METHOD OF SOLICITATION

RFQ IFB RFP

15. DELIVER TO CODE 16. ADMINISTERED BY CODE

17a. CONTRACTOR/OFFEROR CODE FACILITY CODE 18a. PAYMENT WILL BE MADE BY CODE

TELEPHONE NO. UEI: EFT:

PHONE: FAX:

17b. CHECK IF REMITTANCE IS DIFFERENT AND PUT SUCH ADDRESS IN OFFER

18b. SUBMIT INVOICES TO ADDRESS SHOWN IN BLOCK 18a UNLESS BLOCK BELOW IS CHECKED

SEE ADDENDUM

19. 20. 21. 22. 23. 24.

ITEM NO. SCHEDULE OF SUPPLIES/SERVICES QUANTITY UNIT UNIT PRICE AMOUNT

(Use Reverse and/or Attach Additional Sheets as Necessary)

25. ACCOUNTING AND APPROPRIATION DATA 26. TOTAL AWARD AMOUNT (For Govt. Use Only)

27a. SOLICITATION INCORPORATES BY REFERENCE FAR 52.212-1, 52.212-4. FAR 52.212-3 AND 52.212-5 ARE ATTACHED. ADDENDA ARE ARE NOT ATTACHED.

27b. CONTRACT/PURCHASE ORDER INCORPORATES BY REFERENCE FAR 52.212-4. FAR 52.212-5 IS ATTACHED. ADDENDA ARE ARE NOT ATTACHED

28. CONTRACTOR IS REQUIRED TO SIGN THIS DOCUMENT AND RETURN _______________ 29. AWARD OF CONTRACT: REF. ___________________________________ OFFER COPIES TO ISSUING OFFICE. CONTRACTOR AGREES TO FURNISH AND DATED ________________________________. YOUR OFFER ON SOLICITATION DELIVER ALL ITEMS SET FORTH OR OTHERWISE IDENTIFIED ABOVE AND ON ANY (BLOCK 5), INCLUDING ANY ADDITIONS OR CHANGES WHICH ARE ADDITIONAL SHEETS SUBJECT TO THE TERMS AND CONDITIONS SPECIFIED SET FORTH HEREIN IS ACCEPTED AS TO ITEMS:

30a. SIGNATURE OF OFFEROR/CONTRACTOR 31a. UNITED STATES OF AMERICA (SIGNATURE OF CONTRACTING OFFICER)

30b. NAME AND TITLE OF SIGNER (TYPE OR PRINT) 30c. DATE SIGNED 31b. NAME OF CONTRACTING OFFICER (TYPE OR PRINT) 31c. DATE SIGNED

AUTHORIZED FOR LOCAL REPRODUCTION (REV. NOV 2021)

PREVIOUS EDITION IS NOT USABLE Prescribed by GSA - FAR (48 CFR) 53.212

7. FOR SOLICITATION

INFORMATION CALL:

STANDARD FORM 1449

SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES

OFFEROR TO COMPLETE BLOCKS 12, 17, 23, 24, & 30

36C26126Q0661 04-28-2026

LEAH SMITH 702-791-9000 05-06-2026

11:00 AM PDT

612MCP

Department of Veterans Affairs VA Sierra Pacific Network (VISN 21) Network Contracting Office (NCO) 21 3237 Peacekeeper Way, Bldg 209 McClellan Park CA 95652

X

621991

$40 Million

N/A

See Delivery Schedule

612MCP

Department of Veterans Affairs

Network Contracting Office (NCO) 21 3237 Peacekeeper Way, Bldg 209 McClellan CA 95652

Tungsten Electronic Invoicing VA Tungsten Number: AAA544240062 va.registration@tungsten-network.com See VAAR Clause 852.232-72

See CONTINUATION Page

Blood and Blood Products See Statement of Work, Price Cost Schedule, and Estimated Quantity Price Schedule.xls

This is a sole source solicitation to Central California Blood Center IAW RFO Part 12.

Please see Addendum to 52.212-1 Instructions to Offerors for important information on submitting your quote.

Response is due via email only to leah.smith@va.gov, no later than the due date/time shown in box 8.

Questions must be received 2 business days prior to the closing date.

See CONTINUATION Page

Leah Smith Contracting Officer

36C26126Q0661

Table of Contents

SECTION A

A.1 SF 1449 SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL PRODUCTS

AND COMMERCIAL SERVICES

SECTION B - CONTINUATION OF SF 1449 BLOCKS

B.1 CONTRACT ADMINISTRATION DATA

B.2 PRICE/COST SCHEDULE

ITEM INFORMATION

B.3 DELIVERY SCHEDULE

B.4 STATEMENT OF WORK

SECTION C - CONTRACT CLAUSES

C.1 52.252-2 CLAUSES INCORPORATED BY REFERENCE (FEB 1998)

C.2 52.240-91 SECURITY PROHIBITIONS AND EXCLUSIONS (NOV 2025)

(DEVIATION)

C.3 52.252-6 AUTHORIZED DEVIATIONS IN CLAUSES (NOV 2020)

SECTION D - CONTRACT DOCUMENTS, EXHIBITS, OR ATTACHMENTS

SECTION E - SOLICITATION PROVISIONS

ADDENDUM to FAR 52.212-1 INSTRUCTIONS TO OFFERORS—COMMERCIAL

PRODUCTS AND COMMERCIAL SERVICES

E.1 52.252-1 SOLICITATION PROVISIONS INCORPORATED BY REFERENCE (FEB

1998)

E.2 52.212-2 EVALUATION—COMMERCIAL PRODUCTS AND COMMERCIAL

SERVICES (NOV 2021) (DEVIATION OCT 2025)

E.3 52.219-1 SMALL BUSINESS PROGRAM REPRESENTATIONS (NOV 2025)

(DEVIATION)

E.4 52.233-2 SERVICE OF PROTEST (SEP 2006) (DEVIATION NOV 2025)

E.5 52.240-90 SECURITY PROHIBITIONS AND EXCLUSIONS REPRESENTATIONS

AND CERTIFICATIONS (NOV 2025) (DEVIATION)

E.6 52.252-5 AUTHORIZED DEVIATIONS IN PROVISIONS (NOV 2020)

SECTION B - CONTINUATION OF SF 1449 BLOCKS

B.1 CONTRACT ADMINISTRATION DATA

1. Contract Administration: All contract administration matters will be handled by the following individuals:

a. CONTRACTOR:

b. GOVERNMENT: Contracting Officer 36C261 Leah Smith

Network Contracting Office 21

VA Southern Nevada Healthcare System

6900 N. Pecos Road, Building 6

North Las Vegas NV 89086

2. CONTRACTOR REMITTANCE ADDRESS: All payments by the Government to the contractor will be made in accordance with:

[X] 52.232-33, Payment by Electronic Funds Transfer—System For Award Management, or

[] 52.232-36, Payment by Third Party

3. INVOICES: Invoices shall be submitted in arrears:

a. Quarterly []

b. Semi-Annually []

c. Other [X] After delivery, inspection, and acceptance of orders per SOW.

4. GOVERNMENT INVOICE ADDRESS: All Invoices from the contractor shall be submitted electronically in accordance with VAAR Clause 852.232-72 Electronic Submission of Payment Requests.

All invoices from the contractor shall be submitted electronically in accordance with VAAR Clause 852.232-72 Electronic Submission of Payment Requests. VA's Electronic Invoice Presentment and Payment System - The FSC uses a third-party contractor, Tungsten, to transition vendors from paper to electronic invoice submission. Please go to this website:

http://www.tungsten-network.com/US/en/veterans-affairs/ to register and begin submitting electronic invoices, free of charge. The Department of Veterans Affairs Tungsten Number is:

AAA544240062 (this allows you to file invoices online for free.)

More information on the VA Financial Services Center is available at:

http://www.fsc.va.gov/einvoice.asp.

Vendor e-Invoice Set-Up Information:

If you have questions about the e-invoicing program or Tungsten, please contact the FSC at the phone number or email address listed below:

• Tungsten e-Invoice Setup Information: 1-877-489-6135

• Tungsten e-Invoice email: VA.Registration@Tungsten-Network.com

• FSC e-Invoice Contact Information: 1-877-353-9791

• FSC e-invoice email: vafsccshd@va.gov

ACKNOWLEDGMENT OF AMENDMENTS: The offeror acknowledges receipt of amendments to the Solicitation numbered and dated as follows:

AMENDMENT NO DATE

http://www.tungsten-network.com/US/en/veterans-affairs/ http://www.fsc.va.gov/einvoice.asp mailto:VA.Registration@Tungsten-Network.com mailto:vafsccshd@va.gov

B.2 PRICE/COST SCHEDULE

ITEM INFORMATION

ITEM

NUMBER

DESCRIPTION OF

SUPPLIES/SERVICES QUANTITY UNIT UNIT PRICE AMOUNT

1.00 LT __________________ __________________

Fresno VA Estimated Blood and Blood Products

See attached "Estimated Usage Price Schedule" Contract Period: Base POP Begin: 06-01-2026 POP End: 05-31-2027 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): N/A

GRAND TOTAL __________________

B.3 DELIVERY SCHEDULE

ITEM

NUMBER SHIPPING INFORMATION

DELIVERY

DATE

0001 SHIP TO: VACCHCS Blood Bank 2615 East Clinton Ave

FRESNO, CA 94703

USA

6/1/2026 to 5/31/2027

FOB: DESTINATION

B.4 STATEMENT OF WORK

1. INTRODUCTION:

1.1. The Vendor shall furnish and deliver the blood and blood products listed in

“Estimated Usage Price Schedule” on an “AS NEEDED” basis, in appropriate containers, to VA Central California Health Care System (VACCHCS):

VACCHCS Blood Bank 2615 East Clinton Ave Fresno, CA 94703 VA POC: To be included upon award

1.2. Authorized personnel from the VACCHCS will order supplies furnished under this contract on an “AS NEEDED” basis. VA personnel authorized to place orders will be identified after award.

1.3. The Vendor shall provide blood and blood products as available when ordered, and VACCHCS shall purchase blood and blood products according to the appropriate pricing listed in “Estimated Usage Price Schedule”.

1.4. All blood will be tested as required by the Food and Drug Administration (FDA), the American Association of Blood Banks (AABB), all applicable state regulatory agencies, laws, rules and regulations. The Vendor and the VACCHCS shall maintain standards in accordance with FDA, AABB, all applicable state regulatory agencies, laws, rules and regulations, including Occupational Safety and Health Administration (OSHA) Bloodborne Pathogen Exposure Final Rule 29 Code of Federal Regulations (CFR) Part 1910.1030, effective March 2, 1996, and any subsequent revisions thereof.

1.5. All blood shall be collected by the closed system under aseptic conditions and shall be stored in currently approved, appropriate solutions and the container shall be correctly labeled. The label shall also bear the expiration date of the contents which shall not exceed 42 days from date of collection of source blood when collected and stored with anti-coagulant citrate phosphate, dextrose adenine solution (AS) or 35 days from date of collection of source blood, when collected and stored with anti-coagulant citrate phosphate dextrose adenine solution (CPDA1).

1.6. All blood supplies shall be free of hemolysis, and clots, based on The Vendor’s visual inspection of such blood prior to delivery.

1.7. Prior to award The Vendor must submit proof that they hold an unrevoked US license which is issued by the Director, Bureau of Biologics, FDA under Section 351 of the Public Health Service Act, as amended, 42 USC Section 262, as a source of supply for Leukoreduced Red Blood Cells. Vendor shall maintain licensure and accreditation throughout contract period. The Vendor shall comply with the requirements outlined below with respect to donors, containers, delivery, etc.

1.7.1. Vendor shall provide VACCHCS with 100% “volunteer donors” blood in accordance with the latest FDA rules and regulations.

1.7.1.1. Definition of a “volunteer donor”: “A volunteer donor is a person who does not receive monetary payment for blood donation. Benefits, such as monetary time off from work, membership in blood assurance programs and cancellations on non-replacement fees that are not readily convertible to cash, do not constitute monetary payment.”

1.7.2. Blood and blood products shall be delivered to the VACCHCS Blood Bank within two (2) hours for STAT/Emergency orders and four (4) hours for stock orders from the time the order is placed with The Vendor. All Fresh Frozen Plasma shall have expiration dates at least nine (9) months in advance when shipped. The VACCHCS has in place the suitable temperature-monitored freezer and refrigerator for appropriate storage of the products.

2. CRITERIA FOR DONOR SELECTION:

2.1. The Vendor shall maintain a blood donor list with unique identifier numbers.

Such list shall indicate the date the blood of a volunteer donor was furnished to the VACCHCS. Donor selection shall be in accordance with criteria established by the FDA and or American Association of Blood Banks.

2.2. Blood samples testing positive during unit screening shall not be used for transfusion if the results are outside the established limits by FDA and or AABB.

When FDA or AABB requires a new test, it shall be performed.

3. COLLECTION, PROCESSING AND TYPING OF BLOOD:

3.1. Blood shall be typed for ABO & Rh antigens and labeled in accordance with the methods recommended in the current editions of “Standard for Blood Banks and Transfusion Services and Technical methods and Procedures,” published by the

AABB.

3.1.1. If there is an error by The Vendor in the blood typing, The Vendor shall pick up the errant blood immediately.

3.2. All blood shall be collected by closed system under aseptic conditions and shall be processed in appropriate solutions and the container be labeled. The label shall bear the expiration date of the contents which shall not exceed:

3.2.1. 21 days from the date of collection of source blood; or:

3.2.2. 35 days from the date of collection of source blood if when collected, is stored with anti-coagulant citrate phosphate, dextrose adenine solution

(CPDA1).

3.2.3. 42 days from date of collection for blood collected in Adsol.

3.2.4. All blood supplied shall be grossly free of hemolysis, excessive chyle and clots.

4. QUALIFICATIONS:

4.1. All blood and blood products shall be collected, processed, labeled, tested, packaged and shipped in accordance with all regulations of the FDA, Center for Biological Evaluation and review, as described in CFR Title 21, Parts 600, 601, 606, 607, 610, 640, and 660, and the Department of Health and Human Services (DHHS). Also, The Vendor shall maintain a current license with the FDA and the DHHS and maintain accreditation with the AABB. The Vendor shall be accredited by The Joint Commission (TJC) or meet TJC standards and maintain the accreditation or standards. The Vendor shall provide current documentation of above licenses and accreditation to the Contracting Officer (CO) with the proposal, and annually or upon organizational change. The Vendor shall immediately inform the CO concerning any threatened or actual revocation, suspension, or termination or material modification of a certification or licensure.

5. SPECIFICATIONS:

5.1. Volunteer blood donors shall make all donations. The Vendor shall use reasonable efforts to supply the VACCHCS with related service needs. In the event modification of testing of blood for safe usage, as mandated by FDA, Vendor shall provide the CO with 30 days written notice and the CO shall issue a modification.

5.2. Should The Vendor be unable to provide blood components from its inventory to fill an order, The Vendor shall seek other approved sources to obtain such blood components to complete the order. In the event The Vendor fails to fill an order within the estimated timeframe given at the time the order is placed, Vendor shall notify VACCHCS within 30 minutes, and the Government may obtain the item/s elsewhere.

5.3. Vendor shall provide the most current version of the Circular of Information for the use of human blood and blood components to the VACCHCS at no additional charge to the Government.

5.4. Vendor shall not require pre-payment of blood processing & handling surcharges from autologous or designated blood donors for VA. The Vendor shall direct autologous or designated blood donors for VA patients to a facility as decided by VA and the blood center after coordination with COR. In the event a facility for autologous or designated blood donors for VA patient is not feasible for the donor, a community blood center may be used. Shipping fees of blood components shall be incurred by The Vendor. The Vendor shall ship blood components at no additional expense to the VA. These units shall be shipped to VA when received. Autologous donors that have units drawn at The Vendor’s collection sites shall not be required to pay any charges.

5.5. Reference laboratory reports shall be provided to VACCHCS, as soon as testing is completed, by telephone, as this shall provide transfusion records to the patients. A written report shall be issued within seven (7) business days following telephone report. Both telephone and written reports shall be submitted to VACCHCS Blood Bank Technical Specialist, or her/his designee.

5.6. Complex cases may take longer to report and shall be handled on a case by case basis. Mutually agreeable reporting date shall be determined between the VACCHCS Blood Bank Technical Specialist and The Vendor.

6. ORDERING: Orders shall be placed by fax or telephone on an “As Needed” basis by a VACCHCS Blood Bank Technologist at the VACCHCS Blood Bank, VACCHCS.

7. PACKAGING: Blood components shall be labeled in accordance with all FDA requirements, including kind of component, blood group and type (ABO/Rh), expiration date, unique donor unit identification, and storage and handling. Blood components shall be packaged for shipping and transport to ensure the FDA required temperature ranges are maintained: red cell components (1-10◦C), frozen plasma components (below <-20◦C), and platelet components (20-24◦C).

8. DELIVERIES:

8.1. There shall be no additional delivery charges for blood and blood products.

Delivery charges shall be included in the overall price of the blood and blood product. Vendor shall make every effort to make routine deliveries during the time of day suitable to, and as requested by, the VACCHCS.

8.2. The Vendor shall have sole responsibility of the proper care and handling of all blood and blood components, until delivered to the designated VACCHCS Blood Bank in accordance with FAR Clause 52.247-35, F.O.B. destination, within consignee’s premises. All deliveries shall be delivered to the VACCHCS on an “AS NEEDED” basis.

8.2.1. STAT: STAT ordering shall be utilized when products are needed immediately. VACCHCS shall order STAT and expect delivery within two (2) hours. Deliveries shall be seven (7) days per week, twenty-four (24) hours per day “As Needed”.

8.2.2. VACCHCS shall make reasonable efforts to minimize the frequency of STAT deliveries.

8.2.3. No additional charge shall be incurred by the Government for STAT orders.

8.2.4. Vendor shall make every effort to ensure delivery of autologous blood components are made prior to the scheduled surgery. Deglycerolized cells shall be delivered to hospitals within four (4) hours of preparation to assure adequate dating.

8.2.5. Each shipment shall be properly packaged and be accompanied by an itemized shipping list.

9. INSPECTION AND ACCEPTANCE: Upon receipt, VACCHCS shall properly inspect the blood and blood products and maintain proper refrigeration and storage facilities for the blood in compliance with all regulations, as well as the standards of the AABB, as applicable.

9.1. Inspection of Facilities: VACCHCS reserves the right to thoroughly inspect and investigate the establishment, facilities, and other qualifications of The Vendor.

9.2. Reference Lab Services: Reference lab services for red cell antibody identification must be available twenty-four (24) hours per day and seven (7) days per week, and must provide results within four (4) hours for urgent and seven (7) days per week, and must provide results within four (4) hours for urgent clinical situations, and within twenty-four (24) hours in non-urgent situations.

9.3. Plasmapheresis/cytopheresis services must be available twenty-four (24) hours per day and seven (7) days per week and must be available within four (4) hours for urgent clinical situations.

9.4. Plasmapheresis/cytopheresis services are therapeutic procedures performed on patients that have appropriate clinical indications. Automated equipment is used to perform these procedures.

9.5. All pheresis equipment, personnel that operate the equipment and supervisory physicians must satisfy the appropriate regulatory agency guidelines (FDA, AABB, etc.). All pheresis procedures must be under the supervision of a qualified physician.

10. IDENTIFICATION, PARKING, SMOKING, AND VA REGULATIONS: Vendor employees shall wear visible company identification at all times while on VACCHCS property. It is the responsibility of The Vendor employees to park in the appropriate designated parking areas. Information of designated parking areas is available from the VA Police Service. VACCHCS will not invalidate or make reimbursement for parking violations of The Vendor under any conditions. Smoking is prohibited on

VACCHCS property, except in designated areas. Possession of weapons, illegal drugs or alcohol is prohibited. Enclosed containers, including tool kits, shall be subjected to search. Violations of VACCHCS regulations may result in citation answerable in the United States Federal District Court, not a local district, state, or municipal court.

11. HOURS OF OPERATION

Work days: VACCHCS Normal Business Hours are Monday thru Friday, 7:30 AM until 4:30 PM; however, the VACCHCS laboratory is staffed twenty-four (24) hours a day, seven days a week.

Federal Holidays: The following holidays are observed by the Department of Veterans Affairs:

New Year’s Day President’s Day Martin Luther King’s Birthday Memorial Day Juneteenth Independence Day Labor Day Columbus Day Veterans Day Thanksgiving Christmas

The payment for any leave, including sick leave or vacation time, is the responsibility of The Vendor. Periods of any absences are not paid by the VA.

12. COVERAGE:

12.1. Twenty-four (24) hour coverage shall be provided by The Vendor to fill emergency needs when these needs are ordered by VACCHCS. Coverage includes filling blood and blood component orders as requested.

12.2. VACCHCS Blood Bank shall maintain properly monitored temperature refrigeration storage of blood components, and shall abide by directives dictating handling, storage and shipping of blood components and related documentation.

12.3. VACCHCS Blood Bank shall make available, on an as needed basis, its inventory of blood components. Any excess of VACCHCS blood bank immediate patient requirements may be made available for distribution to other hospitals, with approval from the VA Blood Bank. Vendor shall work with the VACCHCS to provide blood component to replenish blood inventory.

12.4. The Vendor shall own, control and solely be responsible for any loss, destruction or damage to the blood until delivered or received, and accepted.

After such delivery or receipt and acceptance, the VACCHCS shall own the blood. The VACCHCS also agree and acknowledge that no blood components supplied by The Vendor, including part and or derivatives thereof, shall be sold, bartered, traded or exchanged by the VACCHCS without prior authorization from The Vendor.

12.5. The VACCHCS Blood Bank shall prioritize the use of appropriate blood components with the shortest dating period and provide to The Vendor after award to ensure optimal utilization of blood components and thereby avoid loss by outdating.

13. ADVERSE EVENT REPORTING: VACCHCS will notify The Vendor of any possible infectious disease or other serious complication associated with transfusion that may have resulted from any of the blood, including suspected post-transfusion hepatitis, transfusion-associated HIV or HTLV infection, and any other transfusion-associated infections (malaria, babesiosis, bacterial contamination or infection) and death.

VACCHCS will make available to The Vendor information concerning transfusions to include product names, lot identifications and quantities, any therapeutic adverse effects, complaints or other pertinent information relating to the blood.

14. REJECTED GOODS: The Vendor shall remove rejected products within 48 hours after notice of rejection.

15. RETURNS: Credit for returned, unacceptable, transferred, recalled, withdrawn, or rotated blood components shall be included on the billing statement within 30 days of the return.

15.1. Full credit shall be given by The Vendor if for a technical reason the blood component cannot be used, regardless of expiration, provided the Government notifies The Vendor within twenty-four (24) hours of discovery and the VACCHCS Blood Bank completes appropriate documentation.

15.2. Full credit shall be given by The Vendor for any Red Blood Cell product returned/exchanged within ten (10) days or greater from the expiration date. If blood is shipped to the transfusion service with ten (10) days or less remaining before expiration date, full credit will be given to VACCHCS if it is returned to The Vendor no later than five (5) days after the expiration date. Full credit will be given to the VACCHCS for Red Blood Cell products not rotated due to an inventory shortage by The Vendor upon return.

15.3. Vendor shall assist with and facilitate the transfer of all blood components to ensure their use. This includes irradiated and other transferrable blood components.

15.4. Red Cells. Vendor shall notify VACCHCS and VACCHCS shall approve Red Blood Cells unit with seven (7) days or less shelf-life remaining prior to delivery.

15.5. Single donor plateletpheresis are returnable and credit will be given if unit is returned with twenty-four (24) hours of shelf life, provided the unit has been continuously stored within 20-24°C with continuous gentle agitation, and the maximum time without agitation is less than twenty-four (24) hours or less, and is unable to use, full credit will be given in the event of expiration date.

16. TRANSFUSION REACTION: VACCHCS Blood Bank shall report to The Vendor within twenty-four (24) hours by telephone any life threatening adverse reactions and if appropriate, make arrangements to have specimen of patient’s blood and the remaining portion of blood component in question sent to Vendor for testing at no additional charge to the Government. VACCHCS Blood Bank shall report to Vendor and assist in investigation of cases of suspected adverse transfusion reactions, including post transfusion hepatitis, post transfusion HTVL-1, and transfusion associated HIV infection within a reasonable period of time not exceeding seven (7) days after learning of the adverse reaction.

17. RECORDS MANAGEMENT: VACCHCS Blood Bank shall maintain thorough and complete records of the recipients of all vendor products to facilitate investigation of transfusion reaction or product recalls. Patient privacy and security safeguards shall be in effect at all times throughout performance of this contract to prevent the loss of sensitive patient data/information and PHI/PII IAW local VA policy.

18. INVOICE AND PAYMENT:

Itemized invoices rendered by The Vendor to VACCHCS for service furnished under this task order shall be invoiced in full for each month in which services were performed. All payments made under this order shall be made monthly in arrears in accordance with FAR Clause 52.212-4. No advance payments will be authorized.

All invoices applicable to this agreement must be submitted no later than thirty (30) days after the end of the contract period. Any problems regarding unpaid invoices should be directed to the CO.

Invoices will be submitted for services, on a monthly basis. At a minimum, each invoice must contain the following:

Invoice number and date Customer Number Payment terms – 1.5/15 net 30 Tax ID Accounts receivable phone number Selling Unit Purchase Order Number Invoice Date Description of services performed, or products supplied Quantity delivered and/or returned Unit cost billed Credit Total Amount All invoices must include the name, title and phone number of person to be notified in the event of defective invoicing.

Invoices must be submitted electronically to:

Department of Veterans Affairs FMS-VA-2 (101) Financial Services Center PO Box 149971 Austin, TX 78714-9971

Fees charged by vendor shall be itemized as processing costs or blood services and are not charges for blood components. Note: Payment of invoices may be delayed if required information listed above and in FAR 52.212-4(g) is not included on the invoice.

All incremental costs during the period of the agreement as a result of additional donor tests mandated by the state, federal agency, and industry practice, shall be the responsibility of the VACCHCS as long as Vendor provides thirty (30) days written notice of such cost, and a bilateral modification is executed by CO. Payment may be retroactive to the 1st day after the 30th day written notification is provided by The Vendor.

19. VACCHCS RESPONSIBILITIES:

19.1. The CO is the only person authorized to approve changes or modify any of the requirements of this contract. The Vendor shall communicate with the CO on all matters pertaining to contract administration. Only the CO is authorized to make commitments or issue any modification to include (but not limited to) terms affecting price, quantity or quality of performance of this contract.

19.2. The CO shall resolve complaints concerning Vendor relations with the Government employees or patients. The CO is final authority on validating complaints. In the event The Vendor effects any such change at the direction of any person other than the CO without authority, no adjustment shall be made in the contract price to cover an increase in costs incurred as a result thereof.

19.3. VA Point of Contact (POC) Responsibilities: The VA POC will be included at award.

The VA POC shall be the VA official responsible for verifying contract compliance. After contract award, any incidents of Vendor noncompliance as evidenced by the monitoring procedures shall be forwarded immediately to the CO.

The VA POC will be responsible for monitoring The Vendor’s performance to ensure all specifications and requirements are fulfilled.

20. NOTIFICATIONS: With respect to Vendor supplied blood, if a blood donor originally tests negative at the time of donation but then during a later donation, tests repeatedly reactive for the HIV antibody, The Vendor shall provide the VACCHCS with the results of follow-up testing required or recommended by the FDA. Vendor shall complete the follow-up testing within thirty (30) days after the donor’s repeatedly reactive screening test. Under no circumstances shall Vendor ever reveal the identity of the blood donor.

Vendor shall promptly notify VACCHCS when new information indicates that blood provided may adversely affect transfusion recipient, provided that vendor shall not reveal the identity of the blood donor.

Upon discovery, VACCHCS shall report to The Vendor any blood lost or missing due to shipping error, and or possible infectious disease or other serious complication associated with transfusion which may have resulted from the blood, including without limitation, suspected post transfusion hepatitis, transfusion associated HIV or HTLV infection, and any other transfusion associated infections such as malaria, babesiosis, bacterial contamination or infection, and death due to adverse event.

VACCHCS shall cooperate with vendor’s investigation of any adverse event and provide information regarding recipient of blood, upon forms provided by vendor, to the extent permissible under the applicable regulations of patient confidentiality.

21. DOCUMENTATION REQUIREMENTS: VACCHCS shall keep complete and accurate records of patients supplied with blood including product name, lot identifications and quantities, any therapeutic adverse effects, complaints and any pertinent information relating to the blood. Patient privacy and security safeguards shall be in effect at all times throughout performance of this contract to prevent the loss of sensitive patient data/information and PHI/PII IAW local VA policy.

22. NOTICES: All notices given or required in the contract shall be provided to each of the parties in writing and delivered by certified or registered U.S. first class mail, return receipt requested, or by recognized national overnight courier service which provides proof of delivery, to the names and addresses set forth in the signature block. Unless otherwise specified in this solicitation, all references to “days” are calendar and not business days.

23. The Vendor shall not employ any person who is an employee of the United States Government if the employment shall create a conflict of interest. The Vendor shall not employ any person who is an employee of the Department of Veterans Affairs unless such person seeks and receives approval in accordance with VA Regulations and public law. Nor shall The Vendor employ any person who is a member of the immediate family of a VA employee employed at VACCHCS, if the employment of that family member shall create a conflict of interest or the appearance of a conflict of interest, particularly with regard to influencing the contract negotiations, terms of the contract or the work carried out under this contract. In any such case, VACCHCS must review the matter and provide approval in accordance with agency ethics regulations.

24. SECURITY CONTROLS COMPLIANCE TESTING: On a periodic basis, VA, including the Office of Inspector General, reserves the right to evaluate any or all of the security controls and privacy practices implemented by The Vendor under the clauses contained within the contract. With ten (10) working-days’ notice, at the request of the government, The Vendor must fully cooperate and assist in a government-sponsored security controls assessment at each location wherein VA information is processed or stored, or information systems are developed, operated, maintained, or used on behalf of VA, including those initiated by the Office of Inspector General. The government may conduct a security control assessment on shorter notice (to include unannounced assessments) as determined by VA in the event of a security incident or at any other time.

25. HIPAA COMPLIANCE: Under HIPAA Privacy and Security Rules, The Vendor providing services under this contract is considered to be a “covered entity,” and thus is not required to enter into a Business Associate Agreement with VA.

However, The Vendor must observe Public Law 104-191 and all respective regulations implementing this law while providing services under this contract.

26. POLICIES/HANDBOOKS: The Vendor shall be subject to the following policies, including any subsequent updates during the period of performance:

VA Directive 1663: Health Care Resources Contracting ‐ Buying http://www1.va.gov/vapubs/viewPublication.asp?Pub_ID=347 VHA Directive 2006‐041 “Veterans Health Care Service Standards” (expired but still in effect pending revision) https://www1.va.gov/vhapublications/ViewPublication.asp?pub_ID=1443 VHA Handbook 1100.17: National Practitioner Data Bank Reports http://www1.va.gov/vhapublications/ViewPublication.asp?pub_ID=2135 VHA Handbook 1100.18 Reporting and Responding to State Licensing Boards http://www1.va.gov/vhapublications/ViewPublication.asp?pub_ID=1364 VHA Handbook 1100.19 Credentialing and Privileging http://www.va.gov/vhapublications/ViewPublication.asp?pub_ID=2910 VHA Handbook 1907.01 Health Information Management and Health Records:

http://www1.va.gov/vhapublications/ViewPublication.asp?pub_ID=2791 Privacy Act of 1974 (5 U.S.C. 552a) as amended http://www1.va.gov/vapubs/viewPublication.asp?Pub_ID=347 http://www1.va.gov/vhapublications/ViewPublication.asp?pub_ID=2135 http://www1.va.gov/vhapublications/ViewPublication.asp?pub_ID=1364 http://www.va.gov/vhapublications/ViewPublication.asp?pub_ID=2910 http://www1.va.gov/vhapublications/ViewPublication.asp?pub_ID=2791 http://www.justice.gov/oip/foia_updates/Vol_XVII_4/page2.htm VHA Handbook 1106.1: Pathology and Laboratory Medicine Service (P&LMS) Procedures (29JAN2016) http://www1.va.gov/vhapublications/ViewPublication.asp?pub_ID=3169

27. DEFINITIONS/ACRONYMS: Terms used in this contract shall be interpreted as follows unless the context expressly requires a different construction and/or interpretation. In case of a conflict in language between the Definitions and other sections of this contract, the language in this section shall govern.

Contracting Officer (CO): The person executing this contract on behalf of the Government with the authority to enter into and administer contracts and make related determinations and findings.

VA Point of Contact (POC): A person appointed to ensure The Vendor performs in accordance with and adheres to the specifications contained in the contract and to protect the interest of the Government. The VA POC shall report to the CO promptly any indication of non‐compliance in order that appropriate action can be taken.

HIPAA: Health Insurance Portability and Accountability Act POP: Period of Performance QASP: Quality Assurance Surveillance Plan VISTA (Veterans Integrated Systems Technology Architecture): A PC based system that will capture and store clinical imagery, scanned documents and other non‐ textual data files and integrates them into patient’s medical record and with the hospital information system.

Veterans Affairs Medical Center (VAMC): Unless identified with the name of a different VA medical Center, for purposes of this contract, this term shall mean VA Central California Healthcare System.

VACCHCS: Veterans Affairs California Healthcare System FDA: Food and Drug Administration DHHS: Department of Health and Human Services CFR: Code of Federal Regulations

[END OF STATEMENT OF WORK]

http://www.justice.gov/oip/foia_updates/Vol_XVII_4/page2.htm http://www1.va.gov/vhapublications/ViewPublication.asp?pub_ID=3169

SECTION C - CONTRACT CLAUSES

C.1 52.252-2 CLAUSES INCORPORATED BY REFERENCE (FEB 1998)

This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this/these address(es):

https://www.acquisition.gov/far-overhaul/far-part-deviation-guide/far-overhaul-part-

52#FAR_52_252_2

https://www.va.gov/oal/library/vaar/

(End of Clause)

FAR

Number

Title Date

52.212-4 CONTRACT TERMS AND CONDITIONS—COMMERCIAL

PRODUCTS AND COMMERCIAL SERVICES (DEVIATION

OCT 2025)

NOV 2023

52.203-6 RESTRICTIONS ON SUBCONTRACTOR SALES TO THE

GOVERNMENT ALTERNATE I (NOV 2021)

JUN 2020

52.203-17 CONTRACTOR EMPLOYEE WHISTLEBLOWER RIGHTS NOV 2023

52.203-19 PROHIBITION ON REQUIRING CERTAIN INTERNAL

CONFIDENTIALITY AGREEMENTS OR STATEMENTS

JAN 2017

52.204-13 SYSTEM FOR AWARD MANAGEMENT—MAINTENANCE

(DEVIATION)

NOV 2025

52.209-6 PROTECTING THE GOVERNMENT'S INTEREST WHEN

SUBCONTRACTING WITH CONTRACTORS DEBARRED,

SUSPENDED, PROPOSED FOR DEBARMENT, OR

VOLUNTARILY EXCLUDED

JAN 2025

52.209-10 PROHIBITION ON CONTRACTING WITH INVERTED

DOMESTIC CORPORATIONS (DEVIATION NOV 2025)

NOV 2015

52.219-8 UTILIZATION OF SMALL BUSINESS CONCERNS

(DEVIATION)

NOV 2025

52.219-28 POSTAWARD SMALL BUSINESS PROGRAM

REREPRESENTATION (DEVIATION)

NOV 2025

52.222-3 CONVICT LABOR (DEVIATION) NOV 2025

52.222-19 CHILD LABOR—COOPERATION WITH AUTHORITIES

AND REMEDIES (DEVIATION)

NOV 2025

52.222-35 EQUAL OPPORTUNITY FOR VETERANS (DEVIATION) NOV 2025

52.222-36 EQUAL OPPORTUNITY FOR WORKERS WITH

DISABILITIES (DEVIATION)

NOV 2025

52.222-37 EMPLOYMENT REPORTS ON VETERANS (DEVIATION) NOV 2025

52.222-40 NOTIFICATION OF EMPLOYEE RIGHTS UNDER THE

NATIONAL LABOR RELATIONS ACT (DEVIATION)

NOV 2025

52.222-50 COMBATING TRAFFICKING IN PERSONS (DEVIATION) NOV 2025

52.223-23 SUSTAINABLE PRODUCTS (DEVIATION) NOV 2025

52.226-8 ENCOURAGING CONTRACTOR POLICIES TO BAN TEXT

MESSAGING WHILE DRIVING

MAY 2024

52.229-4 FEDERAL, STATE, AND LOCAL TAXES (STATE AND

LOCAL ADJUSTMENTS) (DEVIATION)

SEP 2025

52.232-33 PAYMENT BY ELECTRONIC FUNDS TRANSFER—

SYSTEM FOR AWARD MANAGEMENT

OCT 2018

52.232-40 PROVIDING ACCELERATED PAYMENTS TO SMALL

BUSINESS SUBCONTRACTORS

MAR 2023

52.233-3 PROTEST AFTER AWARD (DEVIATION NOV 2025) AUG 1996

52.233-4 APPLICABLE LAW FOR BREACH OF CONTRACT CLAIM

(DEVIATION NOV 2025)

OCT 2004

52.244-

6DEV

SUBCONTRACTS FOR COMMERCIAL PRODUCTS AND

COMMERCIAL SERVICES

OCT 2025

852.203-70 COMMERCIAL ADVERTISING MAY 2018

852.222-71 COMPLIANCE WITH EXECUTIVE ORDER 13899

(DEVIATION) (APR 2025)

APR 2025

852.232-72 ELECTRONIC SUBMISSION OF PAYMENT REQUESTS NOV 2018

852.242-71 ADMINISTRATIVE CONTRACTING OFFICER OCT 2020

852.246-71 REJECTED GOODS OCT 2018

852.247-71 DELIVERY LOCATION OCT 2018

C.2 52.240-91 SECURITY PROHIBITIONS AND EXCLUSIONS (NOV 2025)

(DEVIATION)

(a) Definitions. As used in this clause—

American Security Drone Act-covered foreign entity means an entity included on a list that the Federal Acquisition Security Council (FASC) develops and maintains and publishes in the System for Award Management (SAM) at https://www.sam.gov (section 1822 of Pub. L. 118-31, 41 U.S.C. 3901 note prec.).

Backhaul means intermediate links between the core network, or backbone network, and the small subnetworks at the edge of the network (e.g., connecting cell phones/towers to the core telephone network). Backhaul can be wireless (e.g., microwave) or wired (e.g., fiber optic, coaxial cable, Ethernet).

Covered application means the social networking service TikTok or any successor application or service developed or provided by ByteDance Limited or an entity owned by ByteDance Limited.

Covered article, as defined in 41 U.S.C. 4713(k), means:

(1) Information technology, as defined in 40 U.S.C. 11101, including cloud computing services of all types;

(2) Telecommunications equipment or telecommunications service, as those terms are defined in section 3 of the Communications Act of 1934 (47 U.S.C. 153);

(3) The processing of information on a Federal or non-Federal information system, subject to the requirements of the Controlled Unclassified Information program (see 32 CFR part 2002); or

(4) Hardware, systems, devices, software, or services that include embedded or incidental information technology.

Covered foreign country means The People’s Republic of China.

https://www.sam.gov

Covered telecommunications equipment or services means—

(1) Telecommunications equipment produced by Huawei Technologies Company or ZTE Corporation (or any subsidiary or affiliate of such entities);

(2) For the purpose of public safety, security of Government facilities, physical security surveillance of critical infrastructure, and other national security purposes, video surveillance and telecommunications equipment produced by Hytera Communications Corporation, Hangzhou Hikvision Digital Technology Company, or Dahua Technology Company (or any subsidiary or affiliate of such entities);

(3) Telecommunications or video surveillance services provided by such entities or using such equipment; or

(4) Telecommunications or video surveillance equipment or services produced or provided by an entity that the Secretary of Defense, in consultation with the Director of National Intelligence or the Director of the Federal Bureau of Investigation, reasonably believes to be an entity owned or controlled by, or otherwise connected to, the government of a covered foreign country.

Critical technology means—

(1) Defense articles or defense services included on the United States Munitions List set forth in the International Traffic in Arms Regulations under subchapter M of chapter I of title 22, Code of Federal Regulations;

(2) Items included on the Commerce Control List set forth in Supplement No. 1 to part 774 of the Export Administration Regulations under subchapter C of chapter VII of title 15, Code of Federal Regulations, and controlled—

(i) Pursuant to multilateral regimes, including for reasons relating to national security, chemical and biological weapons proliferation, nuclear nonproliferation, or missile technology; or

(ii) For reasons relating to regional stability or surreptitious listening;

(3) Specially designed and prepared nuclear equipment, parts and components, materials, software, and technology covered by part 810 of title 10, Code of Federal Regulations (relating to assistance to foreign atomic energy activities);

(4) Nuclear facilities, equipment, and material covered by part 110 of title 10, Code of Federal Regulations (relating to export and import of nuclear equipment and material);

(5) Select agents and toxins covered by part 331 of title 7, Code of Federal Regulations, part 121 of title 9 of such Code, or part 73 of title 42 of such Code; or

(6) Emerging and foundational technologies controlled pursuant to section 1758 of the Export Control Reform Act of 2018 (50 U.S.C. 4817).

FASC-prohibited unmanned aircraft system means an unmanned aircraft system manufactured or assembled by an American Security Drone Act—covered foreign entity.

FASCSA order means any of the following orders issued under the Federal Acquisition Supply Chain Security Act (FASCSA) requiring removing covered articles from executive agency information systems or excluding one or more named sources or named covered articles from executive agency procurement actions, as described in 41 CFR 201-1.303(d) and (e):

(1) The Secretary of Homeland Security may issue FASCSA orders that apply to civilian agencies, to the extent not covered by paragraph (2) or (3) of this definition. This type of FASCSA order may be referred to as a Department of Homeland Security (DHS) FASCSA order.

(2) The Secretary of Defense may issue FASCSA orders that apply to the Department of Defense (DoD) and national security systems other than sensitive compartmented information systems. This type of FASCSA order may be referred to as a DoD FASCSA order.

(3) The Director of National Intelligence (DNI) may issue FASCSA orders that apply to the intelligence community and sensitive compartmented information systems, to the extent not covered by paragraph (2) of this definition. This type of FASCSA order may be referred to as a DNI FASCSA order.

Information technology, as defined in 40 U.S.C. 11101(6)—

(1) Means any equipment or interconnected system or subsystem of equipment, used in the automatic acquisition, storage, analysis, evaluation, manipulation, management, movement, control, display, switching, interchange, transmission, or reception of data or information by the executive agency, if the equipment is used by the executive agency directly or is used by a contractor under a contract with the executive agency that requires the use—

(i) Of that equipment; or

(ii) Of that equipment to a significant extent in the performance of a service or the furnishing of a product;

(2) Includes computers, ancillary equipment (including imaging peripherals, input, output, and storage devices necessary for security and surveillance), peripheral equipment designed to be controlled by the central processing unit of a computer, software, firmware and similar procedures, services (including support services), and related resources; but

(3) Does not include any equipment acquired by a Federal contractor incidental to a Federal contract.

Intelligence community, as defined by 50 U.S.C. 3003(4), means the following—

(1) The Office of the Director of National Intelligence;

(2) The Central Intelligence Agency;

(3) The National Security Agency;

(4) The Defense Intelligence Agency;

(5) The National Geospatial-Intelligence Agency;

(6) The National Reconnaissance Office;

(7) Other offices within the Department of Defense for the collection of specialized national intelligence through reconnaissance programs;

(8) The intelligence elements of the Army, the Navy, the Air Force, the Marine Corps, the Coast Guard, the Federal Bureau of Investigation, the Drug Enforcement Administration, and the Department of Energy;

(9) The Bureau of Intelligence and Research of the Department of State;

(10) The Office of Intelligence and Analysis of the Department of the Treasury;

(11) The Office of Intelligence and Analysis of the Department of Homeland Security; or

(12) Such other elements of any department or agency as may be designated by the President, or designated jointly by the Director of National Intelligence and the head of the department or agency concerned, as an element of the intelligence community.

Interconnection arrangement means arrangements governing the physical connection of two or more networks to allow the use of another’s network to hand off traffic where it is ultimately delivered (e.g., connecting a customer of telephone provider A to a customer of telephone company B) or sharing data and other information resources.

Kaspersky Lab-covered article means any hardware, software, or service that—

(1) Is developed or provided by a Kaspersky Lab-covered entity;

(2) Includes any hardware, software, or service developed or provided in whole or in part by a Kaspersky Lab-covered entity; or

(3) Contains components using any hardware or software developed in whole or in part by a Kaspersky Lab-covered entity.

Kaspersky Lab-covered entity means—

(1) Kaspersky Lab;

(2) Any successor entity to Kaspersky Lab, including any change in name, e.g., “Kaspersky”;

(3) Any entity that controls, is controlled by, or is under common control with Kaspersky Lab;

or

(4) Any entity of which Kaspersky Lab has a majority ownership.

National security system, as defined in 44 U.S.C. 3552, means any information system (including any telecommunications system) used or operated by an agency or by a contractor of an agency, or other organization on behalf of an agency—

(1) The function, operation, or use of which involves intelligence activities; involves cryptologic activities related to national security; involves command and control of military forces; involves equipment that is an integral part of a weapon or weapons system; or is critical to the direct fulfillment of military or intelligence missions, but does not include a system that is to be used for routine administrative and business applications (including payroll, finance, logistics, and personnel management applications); or

(2) Is protected at all times by procedures established for information that have been specifically authorized under criteria established by an Executive order or an Act of Congress to be kept classified in the interest of national defense or foreign policy.

Roaming means cellular communications services (e.g., voice, video, data) received from a visited network when unable to connect to the facilities of the home network either because signal coverage is too weak or because traffic is too high.

Sensitive compartmented information means classified information concerning or derived from intelligence sources, methods, or analytical processes, which is required to be handled within formal access control systems established by the Director of National Intelligence.

Sensitive compartmented information system means a national security system authorized to process or store sensitive compartmented information.

Source means a non-Federal supplier, or potential supplier, of products or services, at any tier.

Subsidiary means an entity in which more than 50 percent…